BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 27108533)

  • 21. [Research progress in the third-generation genomic editing technology - CRISPR/Cas9].
    Zhou Y; Zong Y; Kong X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Oct; 33(5):713-6. PubMed ID: 27577230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent Progress in CRISPR/Cas9 Technology.
    Mei Y; Wang Y; Chen H; Sun ZS; Ju XD
    J Genet Genomics; 2016 Feb; 43(2):63-75. PubMed ID: 26924689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRISPR-Cas9: from Genome Editing to Cancer Research.
    Chen S; Sun H; Miao K; Deng CX
    Int J Biol Sci; 2016; 12(12):1427-1436. PubMed ID: 27994508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CRISPR/Cas9: An RNA-guided highly precise synthetic tool for plant genome editing.
    Demirci Y; Zhang B; Unver T
    J Cell Physiol; 2018 Mar; 233(3):1844-1859. PubMed ID: 28430356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utilization of the CRISPR/Cas9 system for the efficient production of mutant mice using crRNA/tracrRNA with Cas9 nickase and FokI-dCas9.
    Terao M; Tamano M; Hara S; Kato T; Kinoshita M; Takada S
    Exp Anim; 2016 Jul; 65(3):275-83. PubMed ID: 26972821
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Græsholt C; Brembu T; Volpe C; Bartosova Z; Serif M; Winge P; Nymark M
    Mar Drugs; 2024 Apr; 22(4):. PubMed ID: 38667802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of genomic changes in a CRISPR/Cas9
    Russo MT; Aiese Cigliano R; Sanseverino W; Ferrante MI
    PeerJ; 2018; 6():e5507. PubMed ID: 30310734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiplexed CRISPR/Cas9 editing of the long-chain acyl-CoA synthetase family in the diatom Phaeodactylum tricornutum reveals that mitochondrial ptACSL3 is involved in the synthesis of storage lipids.
    Hao X; Chen W; Amato A; Jouhet J; Maréchal E; Moog D; Hu H; Jin H; You L; Huang F; Moosburner M; Allen AE; Gong Y
    New Phytol; 2022 Feb; 233(4):1797-1812. PubMed ID: 34882804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [CRISPR-Cas system as molecular scissors for gene therapy].
    Heinz GA; Mashreghi MF
    Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biased and Unbiased Methods for the Detection of Off-Target Cleavage by CRISPR/Cas9: An Overview.
    Martin F; Sánchez-Hernández S; Gutiérrez-Guerrero A; Pinedo-Gomez J; Benabdellah K
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27618019
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phaeodactylum tricornutum: A Diatom Cell Factory.
    Butler T; Kapoore RV; Vaidyanathan S
    Trends Biotechnol; 2020 Jun; 38(6):606-622. PubMed ID: 31980300
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient Targeted Genome Modification in Maize Using CRISPR/Cas9 System.
    Feng C; Yuan J; Wang R; Liu Y; Birchler JA; Han F
    J Genet Genomics; 2016 Jan; 43(1):37-43. PubMed ID: 26842992
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemical Mutagenesis and Fluorescence-Based High-Throughput Screening for Enhanced Accumulation of Carotenoids in a Model Marine Diatom Phaeodactylum tricornutum.
    Yi Z; Su Y; Xu M; Bergmann A; Ingthorsson S; Rolfsson O; Salehi-Ashtiani K; Brynjolfsson S; Fu W
    Mar Drugs; 2018 Aug; 16(8):. PubMed ID: 30081564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiplexed Knockouts in the Model Diatom
    Moosburner MA; Gholami P; McCarthy JK; Tan M; Bielinski VA; Allen AE
    Front Microbiol; 2020; 11():5. PubMed ID: 32047486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of CRISPR/Cas9 system in breeding of new antiviral plant germplasm.
    Zhang DW; Zhang CF; Dong F; Huang YL; Zhang Y; Zhou H
    Yi Chuan; 2016 Sep; 38(9):811-20. PubMed ID: 27644742
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Site-Specific Integration of Exogenous Genes Using Genome Editing Technologies in Zebrafish.
    Kawahara A; Hisano Y; Ota S; Taimatsu K
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of the genome editing tool CRISPR/Cas9 in non-human primates.
    Luo X; Li M; Su B
    Dongwuxue Yanjiu; 2016 Jul; 37(4):214-9. PubMed ID: 27469252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Building the Class 2 CRISPR-Cas Arsenal.
    Lewis KM; Ke A
    Mol Cell; 2017 Feb; 65(3):377-379. PubMed ID: 28157502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficient Genome Editing in Chicken DF-1 Cells Using the CRISPR/Cas9 System.
    Bai Y; He L; Li P; Xu K; Shao S; Ren C; Liu Z; Wei Z; Zhang Z
    G3 (Bethesda); 2016 Apr; 6(4):917-23. PubMed ID: 26869617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation and comparison of CRISPR-Cas9 and Cre-mediated genetically engineered mouse models of sarcoma.
    Huang J; Chen M; Whitley MJ; Kuo HC; Xu ES; Walens A; Mowery YM; Van Mater D; Eward WC; Cardona DM; Luo L; Ma Y; Lopez OM; Nelson CE; Robinson-Hamm JN; Reddy A; Dave SS; Gersbach CA; Dodd RD; Kirsch DG
    Nat Commun; 2017 Jul; 8():15999. PubMed ID: 28691711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.